Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call Transcript

Lumos Pharma, Inc. (NASDAQ:LUMO) Q2 2024 Earnings Call Transcript August 1, 2024

Lumos Pharma, Inc. beats earnings expectations. Reported EPS is $-0.93, expectations were $-1.26.

Operator: Good afternoon and welcome to Lumos Pharma’s Second Quarter 2024 Financial Results and Clinical Programs Update Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference is...